Dietmar Berger, Sanofi CMO and global head of development

Q&A: CMO and de­vel­op­ment chief Di­et­mar Berg­er says Sanofi is 'right there at the table' on di­ver­si­ty ef­forts

Sanofi is de­but­ing its newest di­ver­si­ty ini­tia­tive to­day, a part­ner­ship with his­tor­i­cal­ly Black uni­ver­si­ty Howard Uni­ver­si­ty to help launch the next gen­er­a­tion of sci­en­tists — and Sanofi em­ploy­ees. The pro­gram with Howard’s phar­ma­cy school in­cludes the added ex­tra step of promis­ing jobs at Sanofi to suc­cess­ful can­di­dates.

Help­ing to over­see the pro­gram is Di­et­mar Berg­er, Sanofi’s chief med­ical of­fi­cer and glob­al head of de­vel­op­ment. He joined Sanofi more than three years ago af­ter a short stint at Atara Bio­ther­a­peu­tics, but be­fore that had a long ca­reer in big bio­phar­ma drug de­vel­op­ment. Berg­er, a hema­tol­o­gist-on­col­o­gist, led Genen­tech’s hema­tol­ogy and on­col­o­gy clin­i­cal de­vel­op­ment for six and a half years be­fore Atara. Be­fore that, he led Bay­er’s on­col­o­gy de­vel­op­ment in head can­cers and worked at Am­gen in clin­i­cal de­vel­op­ment for more than 10 years in a va­ri­ety of on­col­o­gy roles.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.